Ironwood Pharmaceuticals’ Jeffrey Silber, SVP and CMO, files initial beneficial ownership statement

PUBT · 2d ago
Ironwood Pharmaceuticals’ Jeffrey Silber, SVP and CMO, files initial beneficial ownership statement
  • Ironwood Pharmaceuticals filed a Form 3 for Jeffrey Silber, SVP, chief medical officer, head of research and drug development.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ironwood Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-312388), on July 22, 2026, and is solely responsible for the information contained therein.